Personalized Pathology & Cancer Therapy

Organisational unit: Research group

Research areas and keywords

UKÄ subject classification

  • Cancer and Oncology


The pathologist’s role is to deliver accurate diagnosis of disease, so as to enable optimal treatment strategies for individual patients. In the wake of the ‘omics revolution, with an increasing availability and impact of a wide range of molecular technologies, clinical pathology is currently undergoing a paradigm shift. However, despite the clear value of these technologies in further refining the diagnostic accuracy and paving the way for personalized medicine, the greatest current challenge is to decipher and reduce the vast amount of information into clinically relevant and applicable assays. The overarching aim of my research is to identify and validate tissue biomarkers for improved prognostication and response prediction in several major types of cancer. In addition, we study the influence of genetic, anthropometric and lifestyle-related factors on cancer development and progression.

Recent research outputs

Wendel, U., Persson, N., Risinger, C., Bengtsson, E., Björn Nodin, Lena Danielsson, Charlotte Welinder, Gunilla Nordin Fredrikson, Bo Jansson & Blixt, O. 2018 Feb 1 In : PLoS ONE. 13, 2, e0191872

Research output: Contribution to journalArticle

Christina Stene, Polistena, A., Gaber, A., Björn Nodin, Ottochian, B., Diya Adawi, Avenia, N., Karin Jirström & Louis Banka Johnson 2018 Jan 1 In : In Vivo. 32, 1, p. 133-138 6 p.

Research output: Contribution to journalArticle

View All (37)